|
|
||||||||
Departments of Pharmacology and Internal Medicine, Division of Nuclear Medicine, The University of Michigan Medical School and Veteran's Administration Medical Center, Ann Arbor, Michigan
Correspondence: For reprints contact: Raymond E. Counsell, PhD, Dept. of Pharmacology, M6322 Medical Science Building I, The University of Michigan Medical School, Ann Arbor, MI 48109-0626.
ABSTRACT
This study was undertaken to determine whether incorporation of radioiodinated cholesterol derivatives into plasma lipoproteins prior to administration to animals could lead to improvements in adrenal localization of radioactivity. Rat high density lipoproteins (HDL) were labeled with [125I]cholesteryl iopanoate, a nonhydrolyzable ester of cholesterol. No enhancement in adrenal uptake of radioactivity was noted at 30 min following administration of the HDL preparation to control rats when compared with [125I]NP-59. However, when animals were made hypolipidemic by treatment with either 4-APP or ethinyl estradiol, the adrenal radioactivity after i.v. administration of the HDL preparation was found to be over 15 times greater than that achieved with [125I]NP-59. Scans of hypolipidemic rats taken at 30 min correlated well with the tissue distribution results.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |